Answers are grounded in this paper and cite their sources.
South India who had microfilaremia and bancroftian filariasis. lvermectin was once orally at four dose levels (range, 25 to 200 μg/kg), and at it was found to be completely effective in clearing blood microfilariae within to 12 days. In most patients, microfilariae reappeared by three months; by months the levels averaged 14% to 32% of pretreatment values in the four groups, and all groups showed equivalent efficacy. Detailed monitoring some side effects in almost all patients: usually fever, headache, lightheadedness, , sore throat, or cough that occurred most prominently 18 36 hours after treatment. These were most frequent and severe in patients the greatest microfilaremia, but only when treated with the two higher doses ivermectin (100 and 200 μg/kg). The low-dose (25 μg/kg) ivermectin group, equivalent efficacy in parasite killing, had clinical reaction scores that minimal and that were not correlated with parasitemia. Since efficacy and effects of ivermectin therapy compare favorably with those reported for with the standard antifilarial drug diethylcarbamazine citrate, the advantage of single-oral-dose administration makes ivermectin the best to replace diethylcarbamazine as the treatment of choice for bancroftian .
No takes yet. Share an insight, caveat, or question.
V. Kumaraswami (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: